Childhood Kidney Diseases

  • 제30권1호
  • /
  • Pages.62-68
  • /
  • 2026
  • /
  • 2384-0242(pISSN)
  • /
  • 2384-0250(eISSN)
대한소아신장학회 (Korean Society of Pediatric Nephrology)
권호 표지
DOI QR코드

DOI QR Code

Early genetic diagnosis of cystinosis before corneal crystal deposition: two case reports from South India

  • Lubna K. P. (Department of Pediatrics, Aster Malabar Institute of Medical Sciences (Aster MIMS)) ;
  • Rehna K. Rahman (Department of Pediatrics, Aster Malabar Institute of Medical Sciences (Aster MIMS)) ;
  • Preetha Remesh (Department of Pediatrics, Aster Malabar Institute of Medical Sciences (Aster MIMS)) ;
  • Manjula Anand (Department of Pediatrics, Aster Malabar Institute of Medical Sciences (Aster MIMS)) ;
  • Nirmal Jayadevan (Department of Ophthalmology, Aster Malabar Institute of Medical Sciences (Aster MIMS)) ;
  • Divya Pachat (Department of Medical Genetics, Aster Malabar Institute of Medical Sciences (Aster MIMS))
  • 투고 : 2025.09.30
  • 심사 : 2026.02.03
  • 발행 : 2026.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Cystinosis is a rare autosomal recessive lysosomal storage disorder with an incidence of approximately 1 in 100,000 to 200,000 live births. It is the most common cause of inherited pediatric Fanconi syndrome (FS). Here, we describe the cases of two infants from unrelated families who presented with polyuria and features of proximal renal tubular dysfunction. Although no corneal cystine deposition was observed at presentation, clinical suspicion and genetic analysis confirmed the diagnosis of nephropathic cystinosis. Both patients carried the same pathogenic variant in the CTNS gene, suggesting that it is a hotspot in this region. These patients were managed with oral cysteamine therapy, cysteamine eye drops, and supportive therapy for FS and are currently doing well. Genetic diagnosis plays a crucial role in the early detection of cystinosis, facilitating timely initiation of cysteamine therapy, and should be considered in infants with FS.

키워드

과제정보

We would like to thank Dr. Sujith V Nayanar, Consultant, Department of Ophthalmology.

참고문헌

  1. Albuquerque ALB, Dos Santos Borges R, Conegundes AF, Dos Santos EE, Fu FMM, Araujo CT, et al. Inherited Fanconi syndrome. World J Pediatr 2023;19:619-34. https://doi.org/10.1007/s12519-023-00685-y
  2. Foreman JW. Fanconi syndrome. Pediatr Clin North Am 2019;66:159-67. https://doi.org/10.1016/j.pcl.2018.09.002
  3. Kiran BV, Barman H, Iyengar A. Clinical profile and outcome of renal tubular disorders in children: a single center experience. Indian J Nephrol 2014;24:362-6. https://doi.org/10.4103/0971-4065.133002
  4. Cherqui S, Courtoy PJ. The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives. Nat Rev Nephrol 2017;13:115-31.
  5. Wilmer MJ, Schoeber JP, van den Heuvel LP, Levtchenko EN. Cystinosis: practical tools for diagnosis and treatment. Pediatr Nephrol 2011;26:205-15. https://doi.org/10.1007/s00467-010-1627-6
  6. Biswas S, Gaviria M, Malheiro L, Marques JP, Giordano V, Liang H, et al. Latest clinical approaches in the ocular management of cystinosis: a review of current practice and opinion from the Ophthalmology Cystinosis Forum. Ophthalmol Ther 2018;7:307-22. https://doi.org/10.1007/s40123-018-0146-6
  7. Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 2000;71:100-20. https://doi.org/10.1006/mgme.2000.3062
  8. Topaloglu R. Extrarenal complications of cystinosis. Pediatr Nephrol 2024;39:2283-92.
  9. Topaloglu R. Nephropathic cystinosis: an update on genetic conditioning. Pediatr Nephrol 2021;36:1347-52. https://doi.org/10.1007/s00467-020-04638-9
  10. Bagga A, Raut S, Khandelwal P, Sinha A, Thakur R, Puraswani M, et al. Infantile nephropathic cystinosis: clinical features and outcome. Asian J Pediatr Nephrol 2020;3:15-20. https://doi.org/10.4103/AJPN.AJPN_10_20
  11. Deepthi B, Krishnamurthy S, Karunakar P, Barathidasan G, Rajavelu TN. Atypical manifestations of infantile-onset nephropathic cystinosis: a diagnostic challenge. CEN Case Rep 2022;11:347-50. https://doi.org/10.1007/s13730-021-00675-x
  12. Deshpande AA, Ravichandran R, Bachhawat AK. Molecular analysis of the CTNS gene in Indians with nephropathic cystinosis. Indian J Pediatr 2017;84:240-1. https://doi.org/10.1007/s12098-016-2257-1
  13. Mathew V, Deepthi B, Krishnasamy S, Yadav P, Sravani M, Ramprabhu GS, et al. Etiology, clinical characteristics, genetic profile, and outcomes of children with refractory rickets at a referral center in India: a cohort study. Pediatr Nephrol 2025;40:1915-27. https://doi.org/10.1007/s00467-025-06656-x
  14. Ariceta G, Giordano V, Santos F. Effects of long-term cysteamine treatment in patients with cystinosis. Pediatr Nephrol 2019;34:571-8. https://doi.org/10.1007/s00467-017-3856-4
  15. Van Stralen KJ, Emma F, Jager KJ, Verrina E, Schaefer F, Laube GF, et al. Improvement in the renal prognosis in nephropathic cystinosis. Clin J Am Soc Nephrol 2011;6:2485-91. https://doi.org/10.2215/CJN.02000311
  16. Bertholet-Thomas A, Berthiller J, Tasic V, Kassai B, Otukesh H, Greco M, et al. Worldwide view of nephropathic cystinosis: results from a survey from 30 countries. BMC Nephrol 2017;18:210. https://doi.org/10.1186/s12882-017-0633-3
  17. Regnier M, Flammier S, Boutaba M, Ndongo AA, Servais A, Schaefer F, et al. Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective. Pediatr Nephrol 2024;39:1113-23. https://doi.org/10.1007/s00467-023-06179-3
  18. Kanakaraj A, Ravichandran R. Cystinosis registry of India: data analysis of patients with cystinosis. Indian J Nephrol 2024;34:100-2.